Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard Hernia Mesh Lawsuit Set To Go Before Jury For Third Bellwether Trial May 15 The Judge also called for parties to propose a trial date for the fourth Bard hernia mesh bellwether trial this week, following unsuccessful attempts to negotiate settlements over past few months February 8, 2023 Irvin Jackson Add Your Comments The U.S. District Judge presiding over more than 18,000 Bard hernia mesh lawsuits has confirmed that a third case will go before a federal jury on May 15, following mixed results in the first two out of a series of planned bellwether trials, which are intended to help the parties gauge how juries will respond to certain evidence and testimony that will be repeated throughout the litigation. Each of the lawsuits raise similar allegations that C.R. Bard has sold various polypropylene mesh products in recent years that were defectively designed and increased the risk of painful complications following hernia repair surgery, including Bard Ventralight, Bard Ventralex, Bard Perfix, Bard 3DMax and other similar mesh systems. Plaintiffs allege they experienced problems after the mesh failed, including severe abdominal pain, infections, adhesions, erosion and other complications, which often result in the need for additional surgery to remove the failed hernia patch. Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in the complaints, the federal litigation has been centralized before U.S. District Judge Edmund A. Sargus in the Southern District of Ohio since August 2018, where the parties have engaged in coordinated discovery in preparation for a series of early trial dates. The first in a series of four planned bellwether trials went before a jury in August 2021, resulting in a defense verdict for the hernia mesh manufacturer. That trial was followed by a second case that went before a jury in April 2022, resulting in a $255,000 verdict. In August 2022, a Bard hernia mesh lawsuit went before a Rhode Island state court jury, resulting in a $4.8 million verdict for one plaintiff, which sent a strong signal to the manufacturer about the extent of liability it may face in certain cases, as each individual lawsuit goes before a jury. Judge Sargus appointed a Bard hernia mesh settlement master later that same month, to work with the parties to determine whether an agreement could be reached to settle large numbers of claims before additional bellwether trials were held. However, no global deal has been reached by the parties. Bard Perfix Plug Lawsuit Set To Go Before Jury May 15, 2023 On February 1, Judge Sargus issued a case management order (PDF) detailing the pretrial and trial schedule leading up to the start of the third bellwether trial case, involving a Bard Perfix Plug lawsuit filed by Robert Stinson, Sr., with two final pretrial conferences set for May 2 and May 3, and trial set to commence on May 15, 2023. Judge Sargus established a deadline of February 17 for plaintiffs to serve an updated witness list, with defendants serving their witness list by February 24. The order also includes deadlines for deposition designations and objections, exhibit lists, motions in limine, voire dire, jury instructions and unresolved objections over the next three months. According to the order, the first week of trial will have five trial days, and the following weeks will alternate between four trial days and five trial days. Both sides will be given 32 hours total to present their cases, not including voire dire, preliminary and final jury instructions, time spent on objections, and opening and closing arguments. In a separate case management order (PDF) issued that same day, Judge Sargus called for parties to present him with a proposed trial date for the fourth Bard hernia mesh bellwether lawsuit this week, which is expected to be scheduled to begin in the late Summer or Fall 2023. 2023 Bard Hernia Mesh Litigation Update While the settlement negotiations continue, and additional hernia mesh trials loom, the size and scope of the litigation has continued to grow as individuals continue to file lawsuits over complications experienced with Bard products. According to the January 2023 docket report (PDF) issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML), there are currently 18,403 lawsuits pending before Judge Sargus, with hundreds of new claims being added each month. If the parties fail to negotiate acceptable average Bard hernia mesh settlements to resolve large numbers of claims in 2023, it is expected that Judge Sargus will consider remanding large numbers of claims back to U.S. District Courts nationwide for individual trial dates in future years. In addition to claims against Bard, thousands of similar claims have been filed in recent years against manufacturers of other polypropylene mesh products that have resulted in widespread injuries, including more than 3,600 Ethicon Physiomesh lawsuits and 3,335 Atrium C-Qur lawsuits which were centralized in separate MDLs, and lawyers involved in each of those proceedings have reached hernia mesh settlements shortly before scheduled bellwether trials were set to begin. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: C. R. Bard, Hernia, Hernia Mesh, Ventralex, Ventralight More Hernia Mesh Lawsuit Stories Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 August 21, 2025 LifeCell Seeks Dismissal of Strattice Hernia Mesh Lawsuit Set for Trial August 11, 2025 Covidien Hernia Mesh Lawsuits Remain on Track for Feb. 2026 Trial Date July 31, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermInstagramThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: today) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: yesterday) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 2 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: today) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: yesterday) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 2 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)